Abstract
Background
Subependymal giant cell astrocytomas (SEGA) are benign tumors characteristic of tuberous sclerosis complex (TSC) that may cause hydrocephalus. Various treatments are nowadays available as mTOR inhibitors or surgery. Surgery is still a valid option especially for symptomatic and larger tumors.
Methods
From January 1994 to December 2015, 31 TSC patients harboring SEGA underwent surgery at the Department of Neurosurgery of the Meyer Pediatric Hospital, Florence. Indications for surgery were tumor size and location, growth and cystization/hemorrhage, and hydrocephalus. Clinical data, preoperative and postoperative MRI, recurrence rate, further surgical procedures, and related complications were analyzed.
Results
A total of 44 surgeries were performed in 31 TSC patients affected by SEGA, achieving gross total removal (GTR) and subtotal removal (STR), respectively, in 36 and 8 patients. Recurrences occurred in 11 patients; 9 of them underwent further surgical procedures and 2 were treated with mTOR pathway inhibitors. Surgical morbidity and mortality were, respectively, 22.7% and 2.3%. After a mean follow-up of 4.9 years, 90% of patients were tumor-free with good neurological status in 93.3%; twelve (40%) had a ventriculo-peritoneal shunt (VPS) for hydrocephalus.
Conclusions
The present series confirms that the surgical approach, combined with mTOR inhibitors, is still a valid option for the treatment of SEGAs.
Similar content being viewed by others
References
Van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S, Lindhout D, van den Ouweland A, Halley D, Young J, Burley M, Jeremiah S, Woodward K, Nahmias J, Fox M, Ekong R, Osborne J, Wolfe J, Povey S, Snell RG, Cheadle JP, Jones AC, Tachataki M, Ravine D, Sampson JR, Reeve MP, Richardson P, Wilmer F, Munro C, Hawkins TL, Sepp T, Ali JB, Ward S, Green AJ, Yates JR, Kwiatkowska J, Henske EP, Short MP, Haines JH, Jozwiak S, Kwiatkowski DJ (1997) Identification of the tuberous sclerosis gene TSC1 on chromosme 9q34. Science 277:805–808
Rieger E, Kerl H (1992) The clinical spectrum of organ manifestations of tuberous sclerosis. Hautarzt. 43(5):272
Bourneville DM (1880) Sclérose tubéreuse des circonvolutions cérébrales: idiote et épilepsie hémiplégique. Arhc Neurol 1:81–91
Nagib MG, Haines SJ, Erickson DL, Mastri AR (1984) Tuberous sclerosis: a review for the neurosurgeon. Neurosurgery 14(1):93–98
O’Callaghan FJK, Martyn CN, Renowden S, Noakes M, Presdee D, Osborne JP (2008) Subependymal nodules, giant-cell astrocytomas and the tuberous sclerosis complex: a population-based study. Arch Dis Child 93:751–754
Curatolo P, Jozwiak S, Nabbout R (2012) Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendation. Eur J Paediatr Neurol 16(6):582–586
Feliciano DM, Lin TV, Hartman NW, Bartley CM, Kubera C, Hsieh L, Lafourcade C, O'Keefe RA, Bordey A (2013) A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits. Int J Dev Neurosci 31(7):667–678
Harter DH, Bassani L, Rodgers SD, Roth J, Devinski O, Carlson C, Wisoff JH, Weiner HL (2014) A management strategy for intraventricular subependymal giant cell astrocytomas in tuberous sclerosis complex. J Neurosurg Pediatrics 13:21–28
Frerebau P, Benezech J, Segnarbieux F, Harbi H, Desy A, Marty-Double C (1985) Intraventricular tumors in tuberous sclerosis. Childs Nerv Syst 1:45–48
McLaurin RL, Towbin RB (1985) Tuberous sclerosis: diagnostic and surgical considerations. Pediatr Neurosci 12:43–48
Sinson G, Sutton LN, Yachnis AT, Duhaime AC, Schut I (1994) Subependymal giant cell astrocytomas in children. Pediatr Neurosurg 20:233–239
Nabbout R, Santos M, Rolland Y, Delalande O, Dulac O, Chiron C (1999) Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis. J Neurol Neurosurg Psychiatry 66(3):370–375
de Ribaupierre S, Vernet O, Vinchon M, Rilliet B (2008) Phacomatoses et tumeurs génétiquement déterminées: la transition enfant-adulte. Neurochirurgie 54:642–653
Katz JS, Milla SS, Wiggins GC, Devinsky O, Weiner HL, Roth J (2012) Intraventricular lesions in tuberous sclerosis complex: a possible association with the caudate nucleus. J Neurosurg Pediatrics 9:406–413
Kim SK, Wang KC, Cho BK, Jung HW, Lee YJ, Chung YS, Lee JY, Park SH, Kim YM, Choe G, Chi JG (2001) Biological behavior and tumorigenesis of subependymal giant cell astrocytomas. J Neuro-Oncol 52:217–225
Goh S, Butler W, Thiele EA (2004) Subependymal giant cell tumors in tuberous sclerosis complex. Neurology 63:1457–1461
Shepherd CW, Gomez MR, Lie JT, Crowson CS (1991) Causes of death in patients with tuberous sclerosis. Mayo Clin Proc 66(8):792–796
Ouyang T, Zhang N, Benjamin T, Wang L, Jiao J, Zhao Y, Chen J (2014) Subependymal giant cell astrocytoma: current concepts, management, and future directions. Childs Nerv Syst 30:561–570
Holanda FJ, Holanda GM (2004) Tuberous sclerosis. Neurosurgical indications in intraventricular tumors. Neurosurg Rev 63:1457–1461
de Ribaupierre S, Dorfmuller G, Bulteau C, Fohlen M, Pinard JM, Chiron C, Delalande O (2007) Subependymal giant-cell astrocytomas in pediatric tuberous sclerosis disease: when should we operate. Neurosurgery 60:83–90
Cuccia V, Zuccaro G, Sosa F, Monges J, Lubieniekey F, Taratuto AL (2003) Subependymal giant cell astrocytoma in children with tuberous sclerosis. Childs Nerv Syst 19:232–243
Kumar R, Singh V (2004) Subependymal giant cell astrocytoma: a report of five cases. Neurosurg Rev 27:274–280
Genitori L, Donati P, Giordano F, Mussa F, Sanzo M, Sardo L, Spacca B, Di Pietro G, Shamsaldin M, Oliveri G (2006) Neurosurgical strategies in the management of subependymal giant cell tumors in tuberous sclerosis complex. Neurocutaneous syndromes in children. In: Curatolo P, Riva D (eds) Chapter 11. John Libbey Eurotext, Montrouge, France. pp 117–138.
Cai R, Di X (2010) Combined intra- and extra-endoscopic techniques for aggressive resection of subependymal Giant cell Astrocytomas. World Neurosurg 73(6):713–718
Roszkowski M, Drabik K, Barszcz S, Jowziak S (1995) Surgical treatment of intraventricular tumors associated with tuberous sclerosis. Childs Nerv Syst 11:335–339
Turgut M, Akalan N, Ozgen T, Ruacan S, Erbengi A (1996) Subependymal giant cell astrocytoma associated with tuberous sclerosis: diagnostic and surgical characteristics of five cases with unusual features. Clin Neurol Neurosurg 98:217–221
Pascual-Castroviejo I, Pascual-Pascual SI, Velazquez-Fragua R, Viano J, Carceller F, Hernandez-Moneo JL, Gutierrez-Molina M, Morales C (2010) Subependymal giant-cell astrocytoma in tuberous sclerosis complex. A presentation of eight paediatric patients. Neurologia 25(5):314–321
Jiang T, Jia G, Ma ZY, Luo SQ, Zhang YQ (2011) The diagnosis and treatment of subependymal giant cell astrocytoma combined with tuberous sclerosis. Childs Nerv Syst 27:55–62
Moavero R, Pinci M, Bombardieri R, Curatolo P (2011) The management of subependymal giant-cell tumors in tuberous sclerosis: a clinician’s perspective. Childs Nerv Syst 27:1203–1210
Pascual-Castroviejo I (2011) Neurosurgical treatment of tuberous sclerosis complex lesions. Childs Nerv Syst 27:1211–1219
Rodgers SD, Bassani L, Weiner HL, Harter DH (2012) Stereotactic endoscopic resection and surgical management of a subependymal giant cell astrocytoma. J Neurosurg Pediatrics 9:417–420
Amin S, Carter M, Edwards RJ, Pople I, Aquilina K, Merrifield J, Osborne JP, O’Callaghan FJK (2013) The outcome of surgical management of subependymal giant cell astrocytoma in tuberous sclerosis complex. Eur J Paediatr Neurol 17:36–44
Jozwiak S, Nabbout R, Curatolo P (2013) Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC) patients: clinical recommendations. Eur J Paediatr Neurol 17:348–352
Roth J, Roach ES, Bartels U, Jozwiak S, Koenig MK, Weiner HL, Franz DN, Wang HZ (2013) Subependymal Giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the international tuberous sclerosis complex consensus conference 2012. Pediatr Neurol 49:439–444
Kotulska K, Borkowska J, Roszkowski M, Mandera M, Dasziewicz P, Drabik K, Jurkiewicz E, Larysz-Brysz M, Nowak K, Grajkowska W, Domanska-Pakiela D, Jozwiak S (2014) Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients. Pediatr Neurol 50:307–312
Franz DN, Belousova E, Sparagana S, Bebin EM, Frost M, Kuperman R, Witt O, Kohrman MH, Flamini JR, Wu JY, Curatolo P, de Vries PJ, Whittemore VH, Thiele EA, Ford JP, Shah G, Cauwel H, Lebwohl D, Sahmoud T, Jozwiak S (2013) Efficacy and safety of Everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multi-center, randomized, placebo-controlled phase 3 trial. Lancet 381(9861):125–132
di Rocco C, Iannelli A, Marchese E (1995) On the treatment of subependymal giant cell astrocytomas and associated hydrocephalus in tuberous sclerosis. Pediatr Neurosurg 23(3):115–121
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Giordano, F., Moscheo, C., Lenge, M. et al. Neurosurgical treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex: a series of 44 surgical procedures in 31 patients. Childs Nerv Syst 36, 951–960 (2020). https://doi.org/10.1007/s00381-019-04449-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-019-04449-w